School of Cancer Medicine
The Olivia Newton-John Cancer Research Institute is affiliated with La Trobe University as the School of Cancer Medicine.
We are discovering, developing and translating innovative cancer treatments and diagnostics that improve outcomes for all people affected by cancer.
Our discoveries are designed with patient needs at the core, driving the development of therapies that are more effective, more tolerable and more accessible.
We are also passionate about training the next generation of cancer researchers in an environment where science and clinical care come together under one roof.
A leader in innovative and effective cancer treatments and diagnostics
Part of a top-ranked university
The School of Cancer Medicine is part of La Trobe University, among the highest ranking universities for life sciences degrees.
Times Higher Education (THE), 2025, Best universities for life sciences degrees in Australia 2025
Access to multi-million dollar platforms
Our students can upskill on advanced techniques and technologies in our state-of-the-art facilities, housing cutting-edge microscopy equipment to sophisticated gene editing platforms.
Truly translational environment
Students have the opportunity to collaborate with clinicians who are embedded in our research teams, ensuring that patient needs at the bedside are the focus of work undertaken at the bench.
Making an impact
The Olivia Newton-John Cancer Research Institute, affiliated with La Trobe University as the School of Cancer Medicine, is discovering, developing and translating innovative cancer treatments and diagnostics that improve outcomes for all people affected by cancer. Our versatile, effective and scalable therapies are designed to benefit a broader range of patients.
Training the next generation of cancer researchers
Connect with us
Events
-
Open Day – Albury-Wodonga Campus
Sunday 16 August 09:00am
-
Open Day – Bendigo Campus
Sunday 23 August 09:00am
News
-
AI tool helps predict bowel cancer relapse risk
AI tool could help predict bowel cancer patients at risk of relapse.
-
Cancer care workforce gap to hit 100 million
Global report warns impending shortage of about 100 million workers.
-
Recruitment for TOP-FLOR trial complete
The TOP-FLOR Phase II clinical trial for patients newly diagnosed with follicular lymphoma (FL) has enrolled the 40th patient.
Indigenous Acknowledgement
La Trobe University proudly acknowledges the traditional custodians of the lands where its campuses are located in Victoria. We recognise that Indigenous Australians have an ongoing connection to the land and the University values their unique contribution to both the University and the wider Australian society. Find out more